1 ANTHRA PHARMACEUTICALS, INC. 103 Carnegie Center, Suite 102 Princeton, NJ 08540 (609) 514-1060 January 18, 1999 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Attention: Filing Desk Re: Anthra Pharmaceuticals, Inc. Registration Statement on Form 8-A File Numbers 000-24107 and 001-14639 Request for Withdrawal Ladies and Gentlemen: Anthra Pharmaceuticals, Inc., a Delaware corporation (the "Registrant"), hereby makes application to immediately withdraw its Registration Statement on Form 8-A (the "8-A Registration Statement"), relating to the Registrant's securities. The Registrant filed the 8-A Registration Statement on November 24, 1998, under Section 12(b) (File No. 001-14639) and Section 12(g) (File No. 000-24107) of the Securities Exchange Act of 1934, as amended (the "'34 Act"). This request for withdrawal of the 8-A Registration Statement is being made because the Registrant will not request effectiveness for its Registration Statement on Form S-1 (Registration No. 333-47725) by the date the 8-A Registration Statement would automatically become effective pursuant to Section 12 of the '34 Act. Should you have any questions regarding this matter, please call our attorney, Joseph V. Cuomo of Morrison & Foerster LLP, at (212) 468-8177. Sincerely, ANTHRA PHARMACEUTICALS, INC. By: /s/ Karen Krumeich ------------------------------------ Karen Krumeich Chief Financial Officer cc: Heather Maples Securities and Exchange Commission Kelly Caralis Boston Stock Exchange Sonja D. Caison The Nasdaq Stock Market, Inc.